Skip to main content

EC 35 Pill: yellow , capsule/oblong, 12mm

The pill with imprint EC 35 (Yellow, Capsule/Oblong1) has been identified as Risedronate Sodium Delayed-Release 35 mg and is used for Prevention of Osteoporosis, Osteoporosis, and Paget's Disease. It belongs to the drug class bisphosphonates and is not a controlled substance.

Images for EC 35

Risedronate sodium delayed-release 35 mg EC 35

Risedronate Sodium Delayed-Release

Imprint
EC 35
Strength
35 mg
Color
Yellow
Size
12.00 mm
Shape
Capsule/Oblong
Availability
Prescription only
Drug Class
Bisphosphonates
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Actavis
Inactive Ingredients
edetate disodium, ferric oxide yellow, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, polysorbate 80, microcrystalline cellulose, silicon dioxide, sodium starch glycolate type A potato, stearic acid, magnesium silicate, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC Code Labeler / Repackager
00430-0979 Warner Chilcott
00591-3876 (Discontinued) Watson Pharmaceuticals, Inc.

Get help with Imprint Code FAQs.

Related images for "EC 35"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.